NextenBio Reports Turnaround in Separate Operating Profit for Q3

Nexten Bio announced on the 14th that it recorded a turnaround in cumulative separate operating profit for the third quarter of this year.

Nexten Bio's cumulative separate sales for the third quarter of this year amounted to 9.95 billion KRW, with an operating profit of 850 million KRW. On a consolidated basis, sales were 24.01 billion KRW, with an operating loss of 550 million KRW. Up to the first half of this year, cumulative separate sales were 3.58039 billion KRW, with an operating loss of 319.74 million KRW.

In particular, the company positively evaluated the recovery to the previous year's level in the third quarter's consolidated sales of 9.89865 billion KRW and operating profit of 466.58 million KRW (previous year same period: sales 10.25415 billion KRW, operating profit 417.59 million KRW). The company analyzed that this was the result of efforts to increase sales by improving profitability through cost rate improvement in the main business CNC automatic lathe division and actively increasing overseas exports to countries such as Turkey based on proactive sales activities.

A Nexten Bio representative said, "We will strive to enhance corporate value based on performance improvement by providing customer value through continuous quality improvement along with active order acquisition efforts both domestically and internationally," adding, "Based on the growth of our core business in ultra-precision equipment, we will create a foundation for sustainable growth through appropriate investments and effective business diversification."